Specifically, we observed that CHK1 was related to differentiation in colorectal cancer, gallbladder cancer, gastric cancer, endometrial cancer, and cervical carcinoma, but not in clear cell renal cell carcinomas and hepatocellular carcinoma. Here, CHEK1 is linked to endometrial cancer.